A review by Kalipso Chalkidou and colleagues published in the Milbank Quarterly compares the characteristics of health technology assessment entities in the UK, France, Germany, and Australia. The full report can be accessed online here; it summarises common themes which may inform current efforts to establish comparative effectiveness research in the US. Firstly, the authors set out the procedures which characterise functioning health technology assessment (such as independence from government, transparency, and scientific rigour). Secondly, they emphasise the evolving role of these organisations, for example in taking on new roles such as influencing national health research agenda. Finally, the review sets out the importance of “selling” the role of health technology assessment to stakeholders, and of setting up appropriate governance and oversight, particularly in relation to conflict of interest policy.
- Supporting Those Who Go to Fight Ebola
- How Knowledge Sharing Moves Countries Towards UHC
- Ebola Virus Disease: Platform for North-South Collaboration Urgently Needed
- Neglected Tropical Diseases that Kill
- Ebola: MSF Should Not Replace Governmental Responsibilities
- Push for Better Death Data Bears Fruit: Largest Ever Global Dataset of Individual Deaths Released
TopicsAfrica antimicrobial drugs antiretroviral treatment cardiovascular health child health china clinical trials developing world diarrhea environment ethics Ghostwriting global burden of disease global health guidelines health costs health information health policy health systems HIV HIV/AIDS influenza LMICs malaria maternal and perinatal health maternal health medical literature medical students Mental Health mortality MSF neglected tropical diseases open access pharmaceutical industry Policy public health reporting research ethics sanitation sub-saharan Africa systematic reviews tuberculosis vaccine water WHO